Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
accelerated approval
acute hepatic porphyria
alnylam pharmaceuticals
aminolevulinic acid
biotech
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cancer vaccine
chronic kidney disease
detroit blog main
detroit top stories
drugs
fda
food and drug administration
forty seven
givosiran
indiana blog main
indiana top stories
investing
ipo
major depressive disorder
medical device
messenger rna
national
national top stories
neoantigens
neon therapeutics
neuronetics
new york blog main
new york top stories
nivolumab
What
nasdaq
2
×
new
2
×
alnylam
biotechs
cleared
club
companies
continued
crop
data
drug
exceeded
far
firms
group
haul
interference
ipo
joined
latest
life
market
medicine
met
million
momentum
neon
offerings
ok
pharmaceuticals
positive
projections
public
raised
record
rna
rnai
rolls
science
sciences
Language
Current search:
nasdaq
×
new
×
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
